INSIGHT

Why we built a 72-point scorecard

A development-stage MedTech company can look busy while still avoiding its hardest questions. That is why we built a 72-point scorecard.

The scorecard is intended to force a structured view across product, evidence, regulation, manufacturing, commercial readiness and governance. It is not a substitute for specialist judgement, and it is not a badge.

Its value is that weak points become visible. Once they are visible, management can decide whether to close them, accept them, or change the route.